The dysfunctional placenta epigenome: Causes and consequences

Epigenomics

Volumn 4, Issue 5, 2012, Pages 561-569

  Lee, Sue Ann ^a   Ding, Chunming ^a  

^a AGENCY FOR SCIENCE   (Singapore)

Author keywords

DNA methylation; epigenetics; imprinting; intrauterine growth restriction; IUGR; miRNA; PE; placenta; preeclampsia; SGA; small for gestational age

Indexed keywords

DNA; RNA;

ADVERSE OUTCOME; ARTICLE; BIRTH WEIGHT; DNA METHYLATION; DNA MODIFICATION; ENVIRONMENTAL FACTOR; EPIGENETICS; FETUS DEVELOPMENT; GENE EXPRESSION; GLUCOSE INTOLERANCE; HUMAN; HYPOXIA; INTRAUTERINE GROWTH RETARDATION; LUNG DEVELOPMENT; MATERNAL NUTRITION; MATERNAL SMOKING; METABOLIC DISORDER; NEUROLOGIC DISEASE; NONHUMAN; PLACENTA; PLACENTA DISORDER; PLACENTA INSUFFICIENCY; PRENATAL DEVELOPMENT; PRIORITY JOURNAL; PROGENY; RNA INTERFERENCE;

ANIMALS; CELL HYPOXIA; DIET, HIGH-FAT; DNA METHYLATION; EPIGENOMICS; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENOMIC IMPRINTING; HUMANS; PLACENTA; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PRENATAL EXPOSURE DELAYED EFFECTS; RISK FACTORS; SMOKING;

EID: 84868526054     PISSN: 17501911     EISSN: 1750192X     Source Type: Journal    
DOI: 10.2217/epi.12.49     Document Type: Article

References (93)

1. Murr R. Interplay between different epigenetic modifications and mechanisms. Adv. Genet. 70, 101-141 (2010).
2. Fowden AL, Moore T. Review: Parent-offspring conflict and the control of placental function. Placenta 33(SUPPL33), S33-S36 (2012).
3. Frost JM, Moore GE. The importance of imprinting in the human placenta. Plos Genet. 6, e1001015 (2010).
4. Fowden AL, Coan PL, Angiolini E, Burton GJ, Constancia M. Imprinted genes and the epigenetic regulation of placental phenotype. Prog. Biophys. Mol. Bio. 106(1), 281-288 (2011).
5. Chiu RW, Chim SS, Wong IH et al. Hypermethylation of RASSF1A in human and rhesus placentae. Am. J. Pathol. 170(3), 941-950 (2007). (Pubitemid 47339363)
6. Wong NC, Novakovic B, Weinrich B et al. Methylation of the adenomatous polyposis coli (APC) gene in human placenta and hypermethylation in choriocarcinoma cells. Cancer Lett. 268(1), 56-62 (2008).
7. Cohen CJ, Rebollo R, Babovic S, Dai EL, Robinson WP, Mager DL. Placenta-specific expression of the interleukin-2 (IL-2) receptor β subunit from an endogenous retroviral promoter. J. Biol. Chem. 286(41), 35543-35552 (2011).
8. Gimenez J, Montgiraud C, Oriol G et al. Comparative methylation of ERVWE1/syncytin-1 and other human endogenous retrovirus LTRs in placenta tissues. DNA Res. 16(4), 195-211 (2009).
9. Chuang HC, Chang CW, Chang GD, Yao TP, Chen H. Hist one deacetylase 3 binds to and regulates the GCMα transcription factor. Nucleic Acids Res. 34, 1459-1469 (2006).
10. Weier JF, Ferlatte C, Weier HU. Somatic genomic variations in extra-embryonic tissues. Curr. Genomics 11(6), 402-408 (2010).
11. Robinson WP, Lauzon JL, Innes AM, Lim K, Arsovska S, McFadden DE. Origin and outcome of pregnancies affected by androgenetic/biparental chimerism. Hum. Reprod. 22, 1114-1122 (2007).
12. Rosenberg MJ, Wolff CR, El-Emawy A, Staples MC, PerrOne-Bizzozero NI, Savage DD. Effects of moderate drinking during pregnancy on placental gene expression. Alcohol 44(7-8), 673-690 (2010).
13. Votavova H, Dostalova Merkerova M, Fejglova K et al. Transcriptome alterations in maternal and fetal cells induced by tobacco smoke. Placenta 32(10), 763-770 (2011).
14. Marouani N, Tebourbi O, Mokni M et al. Embryotoxicity and fetotoxicity following intraperitOneal administrations of hexavalent chromium to pregnant rats. Zygote 19(3), 229-235 (2011).
15. Eriksson JG. Early growth and coronary heart disease and type 2 diabetes: Findings from the Helsinki Birth Cohort Study (HBCS). Am. J. Clin. Nutr. 94(SUPPL6), S1799-S1802 (2011).
16. Gruslin A, Lemyre B. Pre-eclampsia: Fetal assessment and neonatal outcomes. Best Pract. Res. Clin. Obstet. Gynaecol. 25(4), 491-507 (2011).
17. Brosens I, Pijnenborg R, Vercruysse L, Romero R. The "great obstetrical syndromes" are associated with disorders of deep placentation. Am. J. Obstet. Gynecol. 204(3), 193-201 (2011).
18. Senner CE, Hemberger M. Regulation of early trophoblast differentiation - Lessons from the mouse. Placenta 31(11), 944-950 (2010).
19. Szabova L, Son MY, Shi J et al. Membrane-type MMPs are indispensable for placental labyrinth formation and development. Blood 116(25), 5752-5761 (2010).
20. Garcia-Gonzalez MA, Outeda P, Zhou Q et al. Pkd1 and Pkd2 are required for normal placental development. Plos One 5(9), e12821 (2010).
21. Wu G, Imhoff-Kunsch B, Girard AW. Biological mechanisms for nutritional regulation of maternal health and fetal development. Paediatr. Perinat. Epidemiol. 26(SUPPL1), S4-S26 (2012).
22. Aviram A, Hod M, Yogev Y. Maternal obesity: Implications for pregnancy outcome and long-term risks - A link to maternal nutrition. Int. J. Gynaecol. Obstet. 115 (SUPPL1), S6-S10 (2011).
23. Marshall NE, Guild C, Cheng YW, Caughey AB, Halloran DR. Maternal superobesity and perinatal outcomes. Am. J. Obstet. Gynecol. 206(5), 417 e1-e6 (2012).
24. Gallou-Kabani C, Gabory A, Tost J et al. Sex- And diet-specific changes of imprinted gene expression and DNA methylation in mouse placenta under a high-fat diet. Plos One 21, 5(12), e14398 (2010).
25. Frias AE, Morgan TK, Evans AE et al. Maternal high-fat diet disturbs uteroplacental hemodynamics and increases the frequency of stillbirth in a nonhuman primate model of excess nutrition. Endocrinology 152(6), 2456-2464 (2011).
26. Hayes EK, Lechowicz A, Petrik JJ. Adverse fetal and neonatal outcomes associated with a life-long high fat diet: Role of altered development of the placental vasculature. Plos One 7(3), e33370 (2012).
27. McMinn J, Wei M, Schupf N et al. Unbalanced placental expression of imprinted genes in human intrauterine growth restriction. Placenta 27(6-7), 540-549 (2006).
28. Koukoura O, Sifakis S, Soufla G et al. Loss of imprinting and aberrant methylation of IGF2 in placentas from pregnancies complicated with fetal growth restriction. Int. J. Mol. Med. 28(4), 481-487 (2011).
29. Smith AC, Choufani S, Ferreira JC, Weksberg R. Growth regulation, imprinted genes, and chromosome 11p15.5. Pediatr. Res. 61(5 PT2), 43R-47R (2007). (Pubitemid 46653067)
30. Guo L, Choufani S, Ferreira J et al. Altered gene expression and methylation of the human chromosome 11 imprinted region in small for gestational age (SGA) placentae. Dev. Biol. 320(1), 79-91 (2008).
31. Gao WL, Li D, Xiao ZX. Detection of global DNA methylation and paternally imprinted H19 gene methylation in preeclamptic placentas. Hypertens. Res. 34(5), 655-661 (2011).
32. Diplas AI, Lambertini L, Lee MJ et al. Differential expression of imprinted genes in normal and IUGR human placentas. Epigenetics 4(4), 235-240 (2009).
33. Chmurzynska A. Fetal programming: Link between early nutrition, DNA methylation, and complex diseases. Nutr. Rev. 68(2), 87-98 (2010).
34. Goyal R, Goyal D, Leitzke A, Gheorghe CP, Longo LD. Brain renin-angiotensin system: Fetal epigenetic programming by maternal protein restriction during pregnancy. Reprod. Sci. 17(3), 227-238 (2010).
35. Kulkarni A, Dangat K, Kale A, Sable P, Chavan-Gautam P, Joshi S. Effects of altered maternal folic acid, vitamin B12 and docosahexaenoic acid on placental global DNA methylation patterns in Wistar rats. Plos One 6(3), e17706 (2011).
36. McKay JA, Mathers JC. Diet induced epigenetic changes and their implications for health. Acta Physiol. (Oxf.) 202(2), 103-118 (2011).
37. Lillycrop KA, Slater-Jefferies JL, Hanson MA, Godfrey KM, Jackson AA, Burdge GC. Induction of altered epigenetic regulation of the hepatic glucocorticoid receptor in the offspring of rats fed a protein-Restricted diet during pregnancy suggests that reduced DNA methyltransferase-1 expression is involved in impaired DNA methylation and changes in hist one modifications. Br. J. Nutr. 97, 1064-1073 (2007). (Pubitemid 46925358)
38. Simpson JL, Bailey LB, Pietrzik K, Shane B, Holzgreve W. Micronutrients and women of reproductive potential: Required dietary intake and consequences of dietary deficiency or excess. Part I-Folate, vitamin B12, vitamin B6. J. Matern. Fetal Neonatal Med. 23(12), 1323-1343 (2010).
39. Dasarathy J, Gruca LL, Bennett C et al. Methionine metabolism in human pregnancy. Am. J. Clin. Nutr. 91(2), 357-365 (2010).
40. Vacek TP, Vacek JC, Tyagi SC. Mitochondrial mitophagic mechanisms of myocardial matrix metabolism and remodelling. Arch. Physiol. Biochem. 118(1), 31-42 (2012).
41. Ke XD, Foucault-Bertaud A, Genovesio C, Dignat-George F, Lamy E, Charpiot P. Homocysteine modulates the proteolytic potential of human arterial smooth muscle cells through a reactive oxygen species dependant mechanism. Mol. Cell. Biochem. 335(1-2), 203-210 (2010).
42. Tong W, Zhang L. Fetal hypoxia and programming of matrix metalloproteinases. Drug Discov. Today 17(3-4), 124-134 (2012).
43. Pringle KG, Kind KL, Sferruzzi-Perri AN, Thompson JG, Roberts CT. Beyond oxygen, complex regulation and activity of hypoxia inducible factors in pregnancy. Hum. Reprod. Update 16(4), 415-431 (2010).
44. De Marco CS, Caniggia I. Mechanisms of oxygen sensing in human trophoblast cells. Placenta 23(SUPPLA), S58-S68 (2002). (Pubitemid 39658614)
45. Rosario GX, Konno T, Soares MJ. Maternal hypoxia activates endovascular trophoblast cell invasion. Dev. Biol. 314(2), 362-375 (2008).
46. Tal R, Shaish A, Barshack I et al. Effects of hypoxia-inducible factor-1aoverexpression in pregnant mice: Possible implications for preeclampsia and intrauterine growth restriction. Am. J. Pathol. 177(6), 2950-2962 (2010).
47. Roh CR, Budhraja V, Kim HS, Nelson DM, Sadovsky Y. Microarray-Based identification of differentially expressed genes in hypoxic term human trophoblasts and in placental villi of pregnancies with growth restricted fetuses. Placenta 26(4), 319-328 (2005). (Pubitemid 40485869)
48. Nishizawa H, Ota S, Suzuki M et al. Comparative gene expression profiling of placentas from patients with severe pre-eclampsia and unexplained fetal growth restriction. Reprod. Biol. Endocrinol. 9, 107 (2011).
49. Gascoin-Lachambre G, Buffat C, Rebourcet R et al. Cullins in human intra-uterine growth restriction: Expressional and epigenetic alterations. Placenta 31(2), 151-157 (2010).
50. Fu J, Lv X, Lin H et al. Ubiquitin ligase cullin 7 induces epithelial-mesenchymal transition in human choriocarcinoma cells. J. Biol. Chem. 285(14), 10870-10879 (2010).
51. Gheorghe CP, Mohan S, Oberg KC, Longo LD. Gene expression patterns in the hypoxic murine placenta: A role in epigenesis? Reprod. Sci. 14(3), 223-233 (2007). (Pubitemid 351168827)
52. Mouillet JF, Chu T, Hubel CA, Nelson DM, Parks WT, Sadovsky Y. The levels of hypoxia-Regulated microRNAs in plasma of pregnant women with fetal growth restriction. Placenta 31(9), 781-784 (2010).
53. Shruti K, Shrey K, Vibha R. Micro RNAs: Tiny sequences with enormous potential. Biochem. Biophys. Res. Commun. 407(3), 445-449 (2011).
54. Pineles BL, Romero R, Montenegro D et al. Distinct subsets of microRNAs are expressed differentially in the human placentas of patients with preeclampsia. Am. J. Obstet. Gynecol. 196(3), 261. e1-e6 (2007).
55. Mayor-Lynn K, Toloubeydokhti T, Cruz AC, Chegini N. Expression profile of microRNAs and mRNAs in human placentas from pregnancies complicated by preeclampsia and preterm labor. Reprod. Sci. (1), 46-56 (2011).
56. Kuehbacher A, Urbich C, Zeiher AM, Dimmeler S. Role of Dicer and Drosha for endothelial microRNA expression and angiogenesis. Circ. Res. 101(1), 59-68 (2007). (Pubitemid 47094624)
57. Yang WJ, Yang DD, Na S, Sandusky GE, Zhang Q, Zhao G. Dicer is required for embryonic angiogenesis during mouse development. J. Biol. Chem. 280, 9330-9335 (2005). (Pubitemid 40409626)
58. Kim KM, Park SJ, Jung SH et al. miR-182 is a negative regulator of osteoblast proliferation, differentiation, and skeletogenesis through targeting FoxO1. J. BOne Miner. Res. 27(8), 1669-1679 (2012).
59. Contreras J, Rao DS. MicroRNAs in inflammation and immune responses. Leukemia 26(3), 404-413 (2012).
60. Warning JC, McCracken SA, Morris JM. A balancing act: Mechanisms by which the fetus avoids rejection by the maternal immune system. Reproduction 141(6), 715-724 (2011).
61. Bernardi FC, Felisberto F, Vuolo F et al. Oxidative damage, inflammation, and toll-like receptor 4 pathway are increased in preeclamptic patients: A case-Control study. Oxid. Med. Cell. Longev. 636419 (2012).
62. Bobetsis YA, Barros SP, Lin DM et al. Bacterial infection promotes DNA hypermethylation. J. Dent. Res. 86(2), 169-174 (2007).
63. Suter M, Abramovici A, Aagaard-Tillery K. Genetic and epigenetic influences associated with intrauterine growth restriction due to in utero tobacco exposure. Pediatr. Endocrinol. Rev. 8(2), 94-102 (2010).
64. Maccani MA, Avissar-Whiting M, Banister CE, McGonnigal B, Padbury JF, Marsit CJ. Maternal cigarette smoking during pregnancy is associated with downregulation of miR-16, miR-21, and miR-146a in the placenta. Epigenetics 5(7), 583-589 (2010).
65. HuuskOnen P, Storvik M, Reinisalo M et al. Microarray analysis of the global alterations in the gene expression in the placentas from cigarette-smoking mothers. Clin. Pharmacol. Ther. 83, 542-550 (2008). (Pubitemid 351417056)
66. Christensen BC, Houseman EA, Marsit CJ et al. Aging and environmental exposures alter tissue-specific DNA methylation dependent upon CpG island context. Plos Genet. 5, e1000602 (2009).
67. Shoemaker R, Deng J, Wang W, Zhang K. Allele-specific methylation is prevalent and is contributed by CpG-SNPs in the human genome. Genome Res. 20, 883-889 (2010).
68. Yuen RK, Avila L, Penaherrera MS et al. Human placental-specific epipolymorphism and its association with adverse pregnancy outcomes. Plos One 4, e7389 (2009).
69. Jimenez-Chillaron JC, Isganaitis E, Charalambous M et al. Intergenerational transmission of glucose intolerance and obesity by in utero undernutrition in mice. Diabetes 58, 460-468 (2009).
70. Barker DJ. Developmental origins of adult health and disease. J. Epidemiol. Community Health 58, 114 -115 (2004).
71. Jin W, Patti ME. Genetic determinants and molecular pathways in the pathogenesis of Type 2 diabetes. Clin. Sci. 116, 99-111 (2009).
72. Yajnik CS, Deshpande SS, Jackson AA et al. Vitamin B12 and folate concentrations during pregnancy and insulin resistance in the offspring: The Pune Maternal Nutrition Study. Diabetologia 51(1), 29-38 (2008). (Pubitemid 350197985)
73. Ravelli AC, van Der Meulen JH, Osmond C, Barker DJ, Bleker OP. Obesity at the age of 50 y in men and women exposed to famine prenatally. Am. J. Clin. Nutr. 70(5), 811-816 (1999). (Pubitemid 29512905)
74. Barker DJ, Gelow J, Thornburg K, Osmond C, Kajantie E, Eriksson JG. The early origins of chronic heart failure: Impaired placental growth and initiation of insulin resistance in childhood. Eur. J. Heart Fail. 12(8), 819-825 (2010).
75. Laughon M, Bose C, Allred EN et al. Antecedents of chronic lung disease following three patterns of early respiratory disease in preterm infants. Arch. Dis. Child Fetal Neonatal Ed. 96(2), F114-F120 (2011).
76. Karadag A, Sakurai R, Wang Y et al. Effect of maternal food restriction on fetal rat lung lipid differentiation program. Pediatr. Pulmonol. 44(7), 635-644 (2009).
77. Rexhaj E, Bloch J, Jayet PY et al. Fetal programming of pulmonary vascular dysfunction in mice: Role of epigenetic mechanisms. Am. J. Physiol. Heart Circ. Physiol. 301(1), H247-H252 (2011).
78. Susser E, Hoek HW, Brown A. Neurodevelopmental disorders after prenatal famine: The story of the Dutch Famine Study. Am. J. Epidemiol. 147, 213-216 (1998). (Pubitemid 28093130)
79. St Clair D, Xu M, Wang P et al. Rates of adult schizophrenia following prenatal exposure to the Chinese famine of 1959-1961. JAMA 294, 557-562 (2005). (Pubitemid 41126897)
80. Ke X, Lei Q, James SJ et al. Uteroplacental insufficiency affects epigenetic determinants of chromatin structure in brains of neonatal and juvenile IUGR rats. Physiol. Genomics 25, 16-28 (2006).
81. Jensen Peña C, Monk C, Champagne FA. Epigenetic effects of prenatal stress on 11β-hydroxysteroid dehydrogenase-2 in the placenta and fetal brain. Plos One 7(6), e39791 (2012).
82. Wyrwoll CS, Holmes MC. Prenatal excess glucocorticoid exposure and adult affective disorders: A role for serotOnergic and catecholamine pathways. Neuroendocrinology 95(1), 47-55 (2012).
83. Vucetic Z, Totoki K, Schoch H et al. Early life protein restriction alters dopamine circuitry. Neuroscience 168(2), 359-370 (2010).
84. Ramachandran A, Snehalatha C, Shetty AS, Nanditha A. Trends in prevalence of diabetes in Asian countries. World J. Diabetes 3(6), 110-117 (2012).
85. Maclean PS, Bergouignan A, Cornier MA, Jackman MR. Biology's response to dieting: The impetus for weight regain. Am. J. Physiol. Regul. Integr. Comp. Physiol. 301(3) R581-R600 (2011).
86. Stoffers DA, Desai BM, DeLeon DD, Simmons RA. Neonatal exendin-4 prevents the development of diabetes in the intrauterine growth retarded rat. Diabetes 52, 734-740 (2003). (Pubitemid 36323581)
87. Lambertini L, Diplas AI, Lee MJ, Sperling R, Chen J, Wetmur J. A sensitive functional assay reveals frequent loss of genomic imprinting in human placenta. Epigenetics 3, 261-269 (2008).
88. Yuen RK, Penaherrera MS, von Dadelszen P, McFadden DE, Robinson WP. DNA methylation profiling of human placentae reveals promoter hypomethylation of multiple genes in early-onset preeclampsia. Eur. J. Hum. Genet. 18, 1006-1012 (2010).
89. Lo YM, Corbetta N, Chamberlain PF et al. Presence of fetal DNA in maternal plasma and serum. Lancet 350(9076), 485-487 (1997). (Pubitemid 27343304)
90. Illanes S, Parra M, Serra R et al. Increased free fetal DNA levels in early pregnancy plasma of women who subsequently develop preeclampsia and intrauterine growth restriction. Prenat. Diagn. 29(12), 1118-1122 (2009).
91. Sifakis S, Zaravinos A, Maiz N, Spandidos DA, Nicolaides KH. First-trimester maternal plasma cell-free fetal DNA and preeclampsia. Am. J. Obstet. Gynecol. 201(5), 472.e1-e7 (2009).
92. Papageorgiou EA, Karagrigoriou A, Tsaliki E, Velissariou V, Carter NP, Patsalis PC. Fetal-specific DNA methylation ratio permits noninvasive prenatal diagnosis of trisomy 21. Nat. Med. 17(4), 510-513 (2011).
93. Adamo KB, Ferraro ZM, Brett KE. Can we modify the intrauterine environment to halt the intergenerational cycle of obesity? Int. J. Environ. Res. Public Health 9(4), 1263-1307 (2012).